These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17383245)

  • 1. Annular purpura and ulcerative colitis: response to infliximab.
    Tan V; Bartlett M; Hosking P; Gibson PR
    Dig Liver Dis; 2007 May; 39(5):488-9. PubMed ID: 17383245
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis].
    Ainsworth MA; Brynskov J
    Ugeskr Laeger; 2007 Feb; 169(9):789-91. PubMed ID: 17355841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune hemolytic anemia associated with ulcerative colitis: response to infliximab.
    Leo Carnerero E; Aoufi S; Montero Cuadrado I; Herrera Martin P; Herrera Justiniano JM
    Am J Gastroenterol; 2009 Sep; 104(9):2370-1. PubMed ID: 19727107
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
    Fernández A; Velasco A; Prieto V; Canueto J; Alvarez A; Rodríguez A
    Am J Gastroenterol; 2008 Nov; 103(11):2951-2. PubMed ID: 19032482
    [No Abstract]   [Full Text] [Related]  

  • 5. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab for the treatment of ulcerative colitis.
    Eshuis EJ; Bemelman WA; Stokkers PC
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):219-29. PubMed ID: 19485804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus.
    Nakase H; Yamamoto S; Matsuura M; Honzawa Y; Chiba T
    Aliment Pharmacol Ther; 2010 Aug; 32(3):510-1. PubMed ID: 20636704
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue with infliximab and surgical outcomes for refractory ulcerative colitis.
    Actis GC; Pellicano R; Pinna-Pintor M; Rizzetto M
    J Am Coll Surg; 2007 Oct; 205(4):e3-4. PubMed ID: 17903716
    [No Abstract]   [Full Text] [Related]  

  • 11. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
    Mocciaro F; Orlando A; Scimeca D; Cottone M
    Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of infliximab therapy is highly comparable in a Danish and in a Hungarian tertiary center.
    Molnár T; Farkas K; Szepes Z; Nagy F; Wittmann T
    Scand J Gastroenterol; 2011 Feb; 46(2):248-9. PubMed ID: 20923382
    [No Abstract]   [Full Text] [Related]  

  • 13. Retinal vein thrombosis following infliximab treatment for severe left-sided ulcerative colitis.
    Veerappan SG; Kennedy M; O'Morain CA; Ryan BM
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):588-9. PubMed ID: 18467922
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab for ulcerative colitis in children and adolescents.
    McGinnis JK; Murray KF
    J Clin Gastroenterol; 2008 Sep; 42(8):875-9. PubMed ID: 18645529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks.
    Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [TNF-alpha antibody treatment and remission induction in ulcerative colitis: a review of a Cochrane review].
    Bjerrum JT; Munck LC; Krogh-Madsen M; Nielsen OH
    Ugeskr Laeger; 2007 Feb; 169(9):792-5. PubMed ID: 17355842
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical treatment and management of severe ulcerative colitis.
    Rizzello F; Campieri M; Tambasco R; Straforini G; Brugnera R; Poggioli G; Gionchetti P
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S280-4. PubMed ID: 18599001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Listeria meningitis after infliximab treatment of ulcerative colitis.
    Chuang MH; Singh J; Ashouri N; Katz MH; Arrieta AC
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):337-9. PubMed ID: 19841597
    [No Abstract]   [Full Text] [Related]  

  • 19. Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids.
    Rahimi R; Nikfar S; Abdollahi M
    Med Sci Monit; 2007 Jul; 13(7):PI13-8. PubMed ID: 17599035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is keeping the colon the ultimate marker of success in ulcerative colitis?
    Nguyen GC; Prather CM
    Gastroenterology; 2009 Oct; 137(4):1204-6. PubMed ID: 19717125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.